T1	B-Protein	B-Protein	0	3	Tcf	Tcf	B-NP	NN	B-protein	6	NMOD	B-protein
T1	I-Protein	I-Protein	3	4	-	-	B-NP	HYPH	I-protein	1	P	I-protein
T1	I-Protein	I-Protein	4	5	1	1	I-NP	CD	I-protein	1	NMOD	I-protein
O	O	O	5	6	-	-	O	HYPH	O	1	P	O
O	O	O	6	14	mediated	mediate	B-NP	VBN	O	6	NMOD	O
O	O	O	15	28	transcription	transcription	I-NP	NN	O	12	NMOD	O
O	O	O	29	31	in	in	B-PP	IN	O	6	NMOD	O
O	O	O	32	33	T	T	B-NP	NN	B-cell_type	9	NMOD	B-cell_type
O	O	O	34	45	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	7	PMOD	I-cell_type
O	O	O	45	46	:	:	O	:	O	6	P	O
O	O	O	47	59	differential	differential	B-NP	JJ	O	12	NMOD	O
O	O	O	60	64	role	role	I-NP	NN	O	0	ROOT	O
O	O	O	65	68	for	for	B-PP	IN	O	12	NMOD	O
T2	B-Protein	B-Protein	69	77	glycogen	glycogen	B-NP	NN	B-protein	16	NMOD	B-protein
T2	I-Protein	I-Protein	78	86	synthase	synthase	I-NP	NN	I-protein	16	NMOD	I-protein
T2	I-Protein	I-Protein	87	93	kinase	kinase	I-NP	NN	I-protein	13	PMOD	I-protein
T2	I-Protein	I-Protein	93	94	-	-	B-NP	HYPH	O	12	P	O
T2	I-Protein	I-Protein	94	95	3	3	I-NP	CD	O	12	NMOD	O
O	O	O	96	98	in	in	B-PP	IN	O	12	NMOD	O
O	O	O	99	110	fibroblasts	fibroblast	B-NP	NNS	B-cell_type	23	NMOD	B-cell_type
O	O	O	111	114	and	and	O	CC	O	23	NMOD	O
O	O	O	115	116	T	T	B-NP	NN	B-cell_type	23	NMOD	B-cell_type
O	O	O	117	122	cells	cell	B-NP	NNS	I-cell_type	19	PMOD	I-cell_type
O	O	O	122	123	.	.	O	.	O	12	P	O

T3	B-Protein	B-Protein	125	129	Beta	Beta	O	SYM	B-protein	3	NMOD	B-protein
T3	I-Protein	I-Protein	129	130	-	-	O	HYPH	I-protein	3	NMOD	I-protein
T3	I-Protein	I-Protein	130	137	catenin	catenin	B-NP	NN	I-protein	4	SUB	I-protein
O	O	O	138	140	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	141	144	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	145	155	vertebrate	vertebrate	I-NP	JJ	B-protein	7	NMOD	B-protein
O	O	O	156	163	homolog	homolog	I-NP	NN	I-protein	4	PRD	I-protein
O	O	O	164	166	of	of	B-PP	IN	O	7	NMOD	O
O	O	O	167	170	the	the	B-NP	DT	O	14	NMOD	O
T18	B-Entity	B-Entity	171	181	Drosophila	Drosophila	I-NP	FW	B-DNA	14	NMOD	B-DNA
T18	I-Entity	I-Entity	182	189	segment	segment	I-NP	NN	I-DNA	14	NMOD	I-DNA
T18	I-Entity	I-Entity	190	198	polarity	polarity	I-NP	NN	I-DNA	14	NMOD	I-DNA
T18	I-Entity	I-Entity	199	203	gene	gene	I-NP	NN	I-DNA	14	NMOD	I-DNA
T19	I-Entity	I-Entity	204	213	Armadillo	Armadillo	I-NP	NN	B-DNA	8	PMOD	B-DNA
O	O	O	214	217	and	and	O	CC	O	4	VMOD	O
O	O	O	218	223	plays	play	B-VP	VBZ	O	4	VMOD	O
O	O	O	224	229	roles	role	B-NP	NNS	O	16	OBJ	O
O	O	O	230	232	in	in	B-PP	IN	O	16	VMOD	O
O	O	O	233	237	both	both	O	CC	O	25	NMOD	O
O	O	O	238	242	cell	cell	B-NP	NN	O	23	NMOD	O
O	O	O	242	243	-	-	I-NP	HYPH	O	23	NMOD	O
O	O	O	243	247	cell	cell	I-NP	NN	O	23	NMOD	O
O	O	O	248	256	adhesion	adhesion	I-NP	NN	O	25	NMOD	O
O	O	O	257	260	and	and	I-NP	CC	O	25	NMOD	O
O	O	O	261	273	transduction	transduction	I-NP	NN	O	18	PMOD	O
O	O	O	274	276	of	of	B-PP	IN	O	25	NMOD	O
O	O	O	277	280	the	the	B-NP	DT	O	30	NMOD	O
O	O	O	281	284	Wnt	Wnt	I-NP	NN	O	30	NMOD	O
O	O	O	285	294	signaling	signaling	I-NP	NN	O	30	NMOD	O
O	O	O	295	302	cascade	cascade	I-NP	NN	O	26	PMOD	O
O	O	O	302	303	.	.	O	.	O	4	P	O

O	O	O	304	312	Recently	Recently	B-ADVP	RB	O	12	VMOD	O
O	O	O	312	313	,	,	O	,	O	12	P	O
O	O	O	314	321	members	member	B-NP	NNS	O	12	SUB	O
O	O	O	322	324	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	325	328	the	the	B-NP	DT	O	11	NMOD	O
O	O	O	329	332	Lef	Lef	I-NP	NN	B-protein	11	NMOD	B-protein
O	O	O	332	333	/	/	B-NP	SYM	I-protein	11	NMOD	I-protein
O	O	O	333	336	Tcf	Tcf	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	O	337	350	transcription	transcription	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	O	351	357	factor	factor	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	O	358	364	family	family	I-NP	NN	I-protein	4	PMOD	I-protein
O	O	O	365	369	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	370	374	been	be	I-VP	VBN	O	12	VC	O
O	O	O	375	385	identified	identify	I-VP	VBN	O	13	VC	O
O	O	O	386	388	as	as	B-PP	IN	O	14	VMOD	O
O	O	O	389	396	protein	protein	B-NP	NN	O	17	NMOD	O
O	O	O	397	405	partners	partner	I-NP	NNS	O	15	PMOD	O
O	O	O	406	408	of	of	B-PP	IN	O	17	NMOD	O
T4	B-Protein	B-Protein	409	413	beta	beta	B-NP	SYM	B-protein	21	NMOD	B-protein
T4	I-Protein	I-Protein	413	414	-	-	I-NP	HYPH	I-protein	21	NMOD	I-protein
T4	I-Protein	I-Protein	414	421	catenin	catenin	I-NP	NN	I-protein	18	PMOD	I-protein
O	O	O	421	422	,	,	O	,	O	12	P	O
O	O	O	423	433	explaining	explain	B-VP	VBG	O	12	VMOD	O
O	O	O	434	437	how	how	B-ADVP	WRB	O	23	VMOD	O
T5	B-Protein	B-Protein	438	442	beta	beta	O	SYM	B-protein	27	NMOD	B-protein
T5	I-Protein	I-Protein	442	443	-	-	B-NP	HYPH	I-protein	27	NMOD	I-protein
T5	I-Protein	I-Protein	443	450	catenin	catenin	I-NP	NN	I-protein	28	SUB	I-protein
O	O	O	451	457	alters	alter	B-VP	VBZ	O	24	SBAR	O
O	O	O	458	462	gene	gene	B-NP	NN	O	30	NMOD	O
O	O	O	463	473	expression	expression	I-NP	NN	O	28	OBJ	O
O	O	O	473	474	.	.	O	.	O	12	P	O

O	O	O	475	479	Here	Here	B-ADVP	RB	O	3	VMOD	O
O	O	O	480	482	we	we	B-NP	PRP	O	3	SUB	O
O	O	O	483	489	report	report	B-VP	VBP	O	0	ROOT	O
O	O	O	490	494	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	495	497	in	in	B-PP	IN	O	13	VMOD	O
O	O	O	498	499	T	T	B-NP	NN	B-cell_type	7	NMOD	B-cell_type
O	O	O	500	505	cells	cell	I-NP	NNS	I-cell_type	5	PMOD	I-cell_type
O	O	O	505	506	,	,	O	,	O	10	P	O
T6	B-Protein	B-Protein	507	510	Tcf	Tcf	B-NP	NN	B-protein	10	NMOD	B-protein
T6	I-Protein	I-Protein	510	511	-	-	B-NP	HYPH	I-protein	13	SUB	I-protein
T6	I-Protein	I-Protein	511	512	1	1	I-NP	CD	I-protein	10	NMOD	I-protein
O	O	O	513	517	also	also	B-ADVP	RB	O	13	VMOD	O
O	O	O	518	525	becomes	become	B-VP	VBZ	O	4	SBAR	O
O	O	O	526	543	transcriptionally	transcriptionally	B-ADJP	RB	O	15	AMOD	O
O	O	O	544	550	active	active	I-ADJP	JJ	O	13	PRD	O
O	O	O	551	558	through	through	B-PP	IN	O	13	VMOD	O
O	O	O	559	570	interaction	interaction	B-NP	NN	O	16	PMOD	O
O	O	O	571	575	with	with	B-PP	IN	O	17	NMOD	O
T7	B-Protein	B-Protein	576	580	beta	beta	B-NP	SYM	B-protein	21	NMOD	B-protein
T7	I-Protein	I-Protein	580	581	-	-	O	HYPH	I-protein	21	NMOD	I-protein
T7	I-Protein	I-Protein	581	588	catenin	catenin	B-NP	NN	I-protein	18	PMOD	I-protein
O	O	O	588	589	,	,	O	,	O	13	P	O
O	O	O	590	600	suggesting	suggest	B-VP	VBG	O	13	VMOD	O
O	O	O	601	605	that	that	B-SBAR	IN	O	23	VMOD	O
O	O	O	606	609	the	the	B-NP	DT	O	29	NMOD	O
O	O	O	610	613	Wnt	Wnt	I-NP	NN	O	29	NMOD	O
O	O	O	614	620	signal	signal	I-NP	NN	O	29	NMOD	O
O	O	O	621	633	transduction	transduction	I-NP	NN	O	29	NMOD	O
O	O	O	634	641	pathway	pathway	I-NP	NN	O	30	SUB	O
O	O	O	642	644	is	be	B-VP	VBZ	O	24	SBAR	O
O	O	O	645	656	operational	operational	B-ADJP	JJ	O	30	PRD	O
O	O	O	657	659	in	in	B-PP	IN	O	31	AMOD	O
O	O	O	660	661	T	T	B-NP	NN	B-cell_type	34	NMOD	B-cell_type
O	O	O	662	673	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	32	PMOD	I-cell_type
O	O	O	674	676	as	as	B-ADVP	RB	O	30	VMOD	O
O	O	O	677	681	well	well	I-ADVP	RB	O	35	AMOD	O
O	O	O	681	682	.	.	O	.	O	3	P	O

O	O	O	683	690	However	However	B-ADVP	RB	O	39	VMOD	O
O	O	O	690	691	,	,	O	,	O	39	P	O
O	O	O	692	700	although	although	B-SBAR	IN	O	39	VMOD	O
O	O	O	701	704	Wnt	Wnt	B-NP	NN	O	5	NMOD	O
O	O	O	705	712	signals	signal	I-NP	NNS	O	6	SUB	O
O	O	O	713	716	are	be	B-VP	VBP	O	3	SBAR	O
O	O	O	717	722	known	know	I-VP	VBN	O	6	VC	O
O	O	O	723	725	to	to	I-VP	TO	O	9	VMOD	O
O	O	O	726	733	inhibit	inhibit	I-VP	VB	O	7	VMOD	O
O	O	O	734	737	the	the	B-NP	DT	O	11	NMOD	O
O	O	O	738	746	activity	activity	I-NP	NN	O	9	OBJ	O
O	O	O	747	749	of	of	B-PP	IN	O	11	NMOD	O
O	O	O	750	753	the	the	B-NP	DT	O	20	NMOD	O
O	O	O	754	762	negative	negative	I-NP	JJ	B-protein	17	NMOD	B-protein
O	O	O	763	773	regulatory	regulatory	I-NP	JJ	I-protein	17	NMOD	I-protein
O	O	O	774	781	protein	protein	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	O	782	788	kinase	kinase	I-NP	NN	I-protein	20	NMOD	I-protein
T8	B-Protein	B-Protein	789	797	glycogen	glycogen	I-NP	NN	B-protein	20	NMOD	B-protein
T8	I-Protein	I-Protein	798	806	synthase	synthase	I-NP	NN	I-protein	20	NMOD	I-protein
T8	I-Protein	I-Protein	807	813	kinase	kinase	I-NP	NN	I-protein	22	NMOD	I-protein
T8	I-Protein	I-Protein	813	814	-	-	B-NP	HYPH	O	22	NMOD	O
T8	I-Protein	I-Protein	814	819	3beta	3beta	I-NP	NN	O	12	PMOD	O
O	O	O	820	821	(	(	O	(	O	27	DEP	O
T9	B-Protein	B-Protein	821	824	GSK	GSK	B-NP	NN	B-protein	26	NMOD	B-protein
T9	I-Protein	I-Protein	824	825	-	-	B-NP	HYPH	I-protein	26	P	I-protein
T9	I-Protein	I-Protein	825	830	3beta	3beta	I-NP	NN	I-protein	27	DEP	I-protein
O	O	O	830	831	)	)	O	)	O	22	NMOD	O
O	O	O	831	832	,	,	O	,	O	9	P	O
O	O	O	833	842	resulting	result	B-VP	VBG	O	9	VMOD	O
O	O	O	843	845	in	in	B-PP	IN	O	29	VMOD	O
O	O	O	846	855	increased	increase	B-NP	VBN	O	32	NMOD	O
O	O	O	856	862	levels	level	I-NP	NNS	O	30	PMOD	O
O	O	O	863	865	of	of	B-PP	IN	O	32	NMOD	O
T10	B-Protein	B-Protein	866	870	beta	beta	B-NP	SYM	B-protein	36	NMOD	B-protein
T10	I-Protein	I-Protein	870	871	-	-	O	HYPH	I-protein	36	NMOD	I-protein
T10	I-Protein	I-Protein	871	878	catenin	catenin	B-NP	NN	I-protein	33	PMOD	I-protein
O	O	O	878	879	,	,	O	,	O	39	P	O
O	O	O	880	882	we	we	B-NP	PRP	O	39	SUB	O
O	O	O	883	887	find	find	B-VP	VBP	O	0	ROOT	O
O	O	O	888	890	no	no	B-NP	DT	O	41	NMOD	O
O	O	O	891	899	evidence	evidence	I-NP	NN	O	39	OBJ	O
O	O	O	900	903	for	for	B-PP	IN	O	41	NMOD	O
O	O	O	904	915	involvement	involvement	B-NP	NN	O	42	PMOD	O
O	O	O	916	918	of	of	B-PP	IN	O	43	NMOD	O
T11	B-Protein	B-Protein	919	922	GSK	GSK	B-NP	NN	B-protein	47	NMOD	B-protein
T11	I-Protein	I-Protein	922	923	-	-	B-NP	HYPH	I-protein	47	NMOD	I-protein
T11	I-Protein	I-Protein	923	928	3beta	3beta	I-NP	NN	I-protein	44	PMOD	I-protein
O	O	O	929	931	in	in	B-PP	IN	O	43	NMOD	O
O	O	O	932	935	Tcf	Tcf	B-NP	NN	B-protein	52	NMOD	B-protein
O	O	O	935	936	-	-	B-NP	HYPH	O	52	NMOD	O
O	O	O	936	944	mediated	mediate	I-NP	VBN	O	52	NMOD	O
O	O	O	945	958	transcription	transcription	I-NP	NN	O	48	PMOD	O
O	O	O	959	961	in	in	B-PP	IN	O	52	NMOD	O
O	O	O	962	963	T	T	B-NP	NN	B-cell_type	55	NMOD	B-cell_type
O	O	O	964	969	cells	cell	I-NP	NNS	I-cell_type	53	PMOD	I-cell_type
O	O	O	969	970	.	.	O	.	O	39	P	O

O	O	O	971	975	That	That	B-NP	DT	O	9	NMOD	O
O	O	O	976	978	is	be	B-VP	VBZ	O	1	AMOD	O
O	O	O	978	979	,	,	O	,	O	9	P	O
O	O	O	980	981	a	a	B-NP	DT	O	9	NMOD	O
O	O	O	982	990	dominant	dominant	I-NP	JJ	B-protein	9	NMOD	B-protein
O	O	O	991	999	negative	negative	I-NP	JJ	I-protein	9	NMOD	I-protein
T12	B-Protein	B-Protein	1000	1003	GSK	GSK	I-NP	NN	I-protein	9	NMOD	I-protein
T12	I-Protein	I-Protein	1003	1004	-	-	O	HYPH	I-protein	9	NMOD	I-protein
T12	I-Protein	I-Protein	1004	1009	3beta	3beta	B-NP	NN	I-protein	10	SUB	I-protein
O	O	O	1010	1014	does	do	B-VP	VBZ	O	0	ROOT	O
O	O	O	1015	1018	not	not	I-VP	RB	O	10	VMOD	O
O	O	O	1019	1031	specifically	specifically	I-VP	RB	O	10	VMOD	O
O	O	O	1032	1040	activate	activate	I-VP	VB	O	15	VMOD	O
O	O	O	1041	1044	Tcf	Tcf	B-NP	NN	B-protein	15	VMOD	B-protein
O	O	O	1045	1058	transcription	transcription	I-NP	NN	O	17	NMOD	O
O	O	O	1059	1062	and	and	O	CC	O	17	NMOD	O
O	O	O	1063	1070	stimuli	stimulus	B-NP	NNS	O	10	VMOD	O
O	O	O	1071	1072	(	(	O	(	O	17	NMOD	O
O	O	O	1072	1079	lithium	lithium	B-NP	NN	O	18	ROOT	O
O	O	O	1080	1082	or	or	O	CC	O	19	NMOD	O
T13	B-Protein	B-Protein	1083	1101	phytohemagglutinin	phytohemagglutinin	B-NP	NN	B-protein	20	PMOD	B-protein
O	O	O	1101	1102	)	)	O	)	O	21	NMOD	O
O	O	O	1103	1107	that	that	B-NP	WDT	O	22	PMOD	O
O	O	O	1108	1115	inhibit	inhibit	B-VP	VBP	O	23	SBAR	O
T14	B-Protein	B-Protein	1116	1119	GSK	GSK	B-NP	NN	B-protein	28	NMOD	B-protein
T14	I-Protein	I-Protein	1119	1120	-	-	B-NP	HYPH	O	28	NMOD	O
T14	I-Protein	I-Protein	1120	1125	3beta	3beta	I-NP	NN	O	28	NMOD	O
O	O	O	1126	1134	activity	activity	I-NP	NN	O	24	OBJ	O
O	O	O	1135	1139	also	also	B-ADVP	RB	O	24	VMOD	O
O	O	O	1140	1142	do	do	B-VP	VBP	O	24	VMOD	O
O	O	O	1143	1146	not	not	I-VP	RB	O	30	VMOD	O
O	O	O	1147	1155	activate	activate	I-VP	VB	O	30	VC	O
T20	B-Entity	B-Entity	1156	1159	Tcf	Tcf	B-NP	NN	B-DNA	35	NMOD	B-DNA
T20	I-Entity	I-Entity	1160	1168	reporter	reporter	I-NP	NN	I-DNA	35	NMOD	I-DNA
T20	I-Entity	I-Entity	1169	1174	genes	gene	I-NP	NNS	I-DNA	32	OBJ	I-DNA
O	O	O	1174	1175	.	.	O	.	O	19	P	O

O	O	O	1176	1180	Thus	Thus	B-ADVP	RB	O	8	VMOD	O
O	O	O	1180	1181	,	,	O	,	O	8	P	O
O	O	O	1182	1192	inhibition	inhibition	B-NP	NN	O	8	SUB	O
O	O	O	1193	1195	of	of	B-PP	IN	O	3	NMOD	O
T15	B-Protein	B-Protein	1196	1199	GSK	GSK	B-NP	NN	B-protein	7	NMOD	B-protein
T15	I-Protein	I-Protein	1199	1200	-	-	B-NP	HYPH	I-protein	7	NMOD	I-protein
T15	I-Protein	I-Protein	1200	1205	3beta	3beta	I-NP	NN	I-protein	4	PMOD	I-protein
O	O	O	1206	1208	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	1209	1221	insufficient	insufficient	B-ADJP	JJ	O	8	PRD	O
O	O	O	1222	1224	to	to	B-VP	TO	O	11	VMOD	O
O	O	O	1225	1233	activate	activate	I-VP	VB	O	9	AMOD	O
O	O	O	1234	1237	Tcf	Tcf	B-NP	NN	B-protein	15	NMOD	B-protein
O	O	O	1237	1238	-	-	B-NP	HYPH	O	15	NMOD	O
O	O	O	1238	1247	dependent	dependent	I-NP	JJ	O	15	NMOD	O
O	O	O	1248	1261	transcription	transcription	I-NP	NN	O	11	OBJ	O
O	O	O	1262	1264	in	in	B-PP	IN	O	15	NMOD	O
O	O	O	1265	1266	T	T	B-NP	NN	B-cell_type	18	NMOD	B-cell_type
O	O	O	1267	1278	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	16	PMOD	I-cell_type
O	O	O	1278	1279	.	.	O	.	O	8	P	O

O	O	O	1280	1282	In	In	B-PP	IN	O	10	VMOD	O
O	O	O	1283	1291	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	O	1291	1292	,	,	O	,	O	10	P	O
O	O	O	1293	1295	in	in	B-PP	IN	O	10	VMOD	O
O	O	O	1296	1301	C57MG	C57MG	B-NP	NN	B-cell_line	7	NMOD	B-cell_line
O	O	O	1302	1312	fibroblast	fibroblast	I-NP	NN	I-cell_line	7	NMOD	I-cell_line
O	O	O	1313	1318	cells	cell	I-NP	NNS	I-cell_line	4	PMOD	I-cell_line
O	O	O	1318	1319	,	,	O	,	O	10	P	O
O	O	O	1320	1327	lithium	lithium	B-NP	NN	O	10	SUB	O
O	O	O	1328	1339	inactivates	inactivate	B-VP	VBZ	O	0	ROOT	O
T16	B-Protein	B-Protein	1340	1343	GSK	GSK	B-NP	NN	B-protein	13	NMOD	B-protein
T16	I-Protein	I-Protein	1343	1344	-	-	I-NP	HYPH	O	13	NMOD	O
T16	I-Protein	I-Protein	1344	1349	3beta	3beta	I-NP	NN	O	10	OBJ	O
O	O	O	1350	1353	and	and	O	CC	O	10	VMOD	O
O	O	O	1354	1361	induces	induce	B-VP	VBZ	O	10	VMOD	O
T17	B-Protein	B-Protein	1362	1365	Tcf	Tcf	B-NP	NN	B-protein	19	NMOD	B-protein
O	O	O	1365	1366	-	-	O	HYPH	O	19	NMOD	O
O	O	O	1366	1376	controlled	control	B-NP	VBN	O	19	NMOD	O
O	O	O	1377	1390	transcription	transcription	I-NP	NN	O	15	OBJ	O
O	O	O	1390	1391	.	.	O	.	O	10	P	O

O	O	O	1392	1396	This	This	B-NP	DT	O	2	SUB	O
O	O	O	1397	1399	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	1400	1403	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	1404	1409	first	first	I-NP	JJ	O	5	NMOD	O
O	O	O	1410	1423	demonstration	demonstration	I-NP	NN	O	2	OBJ	O
O	O	O	1424	1428	that	that	B-NP	IN	O	5	NMOD	O
O	O	O	1429	1436	lithium	lithium	B-NP	NN	O	8	SUB	O
O	O	O	1437	1440	can	can	B-VP	MD	O	6	SBAR	O
O	O	O	1441	1446	alter	alter	I-VP	VB	O	8	VC	O
O	O	O	1447	1451	gene	gene	B-NP	NN	O	11	NMOD	O
O	O	O	1452	1462	expression	expression	I-NP	NN	O	9	OBJ	O
O	O	O	1463	1465	of	of	B-PP	IN	O	11	NMOD	O
T21	B-Entity	B-Entity	1466	1469	Tcf	Tcf	B-NP	NN	B-DNA	16	NMOD	B-DNA
T21	I-Entity	I-Entity	1469	1470	-	-	B-NP	HYPH	I-DNA	16	NMOD	I-DNA
T21	I-Entity	I-Entity	1470	1480	responsive	responsive	I-NP	JJ	I-DNA	16	NMOD	I-DNA
T21	I-Entity	I-Entity	1481	1486	genes	gene	I-NP	NNS	I-DNA	12	PMOD	I-DNA
O	O	O	1486	1487	,	,	O	,	O	2	P	O
O	O	O	1488	1491	and	and	O	CC	O	2	VMOD	O
O	O	O	1492	1498	points	point	B-VP	VBZ	O	2	VMOD	O
O	O	O	1499	1501	to	to	B-PP	TO	O	19	VMOD	O
O	O	O	1502	1503	a	a	B-NP	DT	O	22	NMOD	O
O	O	O	1504	1514	difference	difference	I-NP	NN	O	20	PMOD	O
O	O	O	1515	1517	in	in	B-PP	IN	O	22	NMOD	O
O	O	O	1518	1528	regulation	regulation	B-NP	NN	O	23	PMOD	O
O	O	O	1529	1531	of	of	B-PP	IN	O	24	NMOD	O
T22	B-Entity	B-Entity	1532	1535	Wnt	Wnt	B-NP	NN	O	27	NMOD	O
O	O	O	1536	1545	signaling	signaling	I-NP	NN	O	25	PMOD	O
O	O	O	1546	1553	between	between	B-PP	IN	O	27	NMOD	O
O	O	O	1554	1565	fibroblasts	fibroblast	B-NP	NNS	B-cell_type	31	NMOD	B-cell_type
O	O	O	1566	1569	and	and	I-NP	CC	O	31	NMOD	O
O	O	O	1570	1581	lymphocytes	lymphocyte	I-NP	NNS	B-cell_type	28	PMOD	B-cell_type
O	O	O	1581	1582	.	.	O	.	O	2	P	O
